Table 1.
Comparisons of the clinical parameters in non-diabetic controls and diabetic patients at baseline.
| Non-diabetic controls (n = 55) | Diabetics (n = 85) | P | |
|---|---|---|---|
| Female | 56.4% (n = 31) | 68.2% (n = 58) | 0.154 |
| Male | 43.6% (n = 24) | 31.8% (n = 27) | |
| Age (years) | 52.61 ± 4.88 | 54.81 ± 10.53 | 0.153 |
| Duration of diabetes (year) | – | 11.71 ± 6.91 | – |
| Body weight (kg) | 85.56 ± 10.53 | 87.83 ± 18.27 | 0.405 |
| BMI (kg/m2) | 31.63 ± 3.57 | 33.44 ± 6.48 | 0.061 |
| WC (cm) | 103.76 ± 7.07 | 107.45 ± 11.94 | 0.052 |
| FPG (mg/dl) | 94.90 ± 11.41 | 183.91 ± 66.91 | <0.001 |
| HbA1c (%) | 5.46 ± 0.32 | 8.52 ± 1.55 | <0.001 |
| HbA1c (mmol/mol) | 36.18 ± 3.52 | 69.67 ± 17.04 | <0.001 |
| LDL-C ((mg/dl) | 138.55 ± 36.50 | 122.16 ± 32.08 | 0.009 |
| LDL-C (mmol/L) | 7.69 ± 2.02 | 6.78 ± 1.78 | 0.009 |
| TG (mg/dl) | 143.56 ± 88.44 | 229.97 ± 162.56 | <0.001 |
| TG (mmol/L) | 7.96 ± 4.79 | 12.76 ± 9.02 | <0.001 |
| HDL-C (mg/dl) | 54.34 ± 12.66 | 43.78 ± 9.11 | <0.001 |
| HDL-C (mmol/L) | 3.07 ± 0.70 | 2.43 ± 0.51 | <0.001 |
Data are shown as mean ± SD (standard deviation) or percentage (%).
p < 0.05 was expressed as statistically significant. Significant values were shown in bold.
Abbreviations: BMI, body weight index; WC, waist circumference; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; LDL-C, low-density lipoprotein-cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein-cholesterol.